Cellectis Other Stockholder Equity from 2010 to 2025

CLLS Stock  USD 1.27  0.03  2.31%   
Cellectis Other Stockholder Equity yearly trend continues to be comparatively stable with very little volatility. Other Stockholder Equity will likely drop to about 440.2 M in 2025. From the period from 2010 to 2025, Cellectis Other Stockholder Equity quarterly data regression had r-value of  0.68 and coefficient of variation of  66.89. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2008-12-31
Previous Quarter
607.2 M
Current Value
494.3 M
Quarterly Volatility
310.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.8 M, Interest Expense of 7.8 M or Selling General Administrative of 29.7 M, as well as many indicators such as Price To Sales Ratio of 3.47, Dividend Yield of 0.0 or PTB Ratio of 1.1. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Cellectis SA over the last few years. It is Cellectis' Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Cellectis Other Stockholder Equity Regression Statistics

Arithmetic Mean468,901,516
Geometric Mean0.00
Coefficient Of Variation66.89
Mean Deviation245,235,767
Median497,452,778
Standard Deviation313,645,819
Sample Variance98373.7T
Range934.7M
R-Value0.68
Mean Square Error56500.7T
R-Squared0.46
Significance0
Slope44,872,224
Total Sum of Squares1475605.5T

Cellectis Other Stockholder Equity History

2025440.2 M
2024494.3 M
2023522.8 M
2022583.1 M
2021934.7 M
2020863.9 M
2019843.5 M

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Stockholder Equity494.3 M440.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.